Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
RBBP4/RbAp48 Antibody (JU37-47), Novus Biologicals™

Rabbit Monoclonal Antibody
Supplier: Novus Biologicals NBP275642
Description
RBBP4/RbAp48 Monoclonal specifically detects RBBP4/RbAp48 in Human, Mouse, Rat samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin.Specifications
RBBP4/RbAp48 | |
Monoclonal | |
1 mg/mL | |
Western Blot 1:100-1:2000, Flow Cytometry 1:10-1:1000, Immunohistochemistry 1:10 - 1:500, Immunocytochemistry/Immunofluorescence 1:10 - 1:500, Immunoprecipitation 1:10 - 1:500, Immunohistochemistry-Paraffin | |
CAF-1 subunit C, CAF-I p48, Chromatin assembly factor 1 subunit C, Chromatin assembly factor I p48 subunit, chromatin assembly factor/CAF-1 p48 subunit, histone-binding protein RBBP4, MSI1 protein homolog, Nucleosome-remodeling factor subunit RBAP48, NURF55, RbAp48, RBBP-4, retinoblastoma binding protein 4, Retinoblastoma-binding protein 4CAF-I 48 kDa subunit, Retinoblastoma-binding protein p48 | |
Rabbit | |
48 kDa | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Purified |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation | |
JU37-47 | |
Unconjugated | |
TBS (pH7.4), 0.05% BSA, 40% Glycerol with 0.05% Sodium Azide | |
RBBP4 | |
Recombinant protein within Human RBBP4/RbAp48 aa 1-98/ 425. (SwissProt: Q09028 Human; SwissProt: Q60972 Mouse) | |
Protein A purified | |
Cancer, Cell Cycle and Replication, Chromatin Research, Growth and Development, Stem Cell Markers, Tumor Suppressors | |
5928.0 | |
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction